Latest News and Press Releases
Want to stay updated on the latest news?
-
- Confirmed Maximum Dose for EC1169 and Initiated Expansion Phase in Prostate Cancer Patients -- First Confirmed RECIST Partial Response Observed in EC1169 Dose Escalation Reported at European Society...
-
WEST LAFAYETTE, Ind., Nov. 02, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc., (NASDAQ:ECYT) announced today that the company will host a conference call on Wednesday, Nov. 9th, at 4:30 p.m. EST to discuss...
-
WEST LAFAYETTE, Ind., Nov. 01, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
-
WEST LAFAYETTE, Ind., Oct. 10, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
-
WEST LAFAYETTE, Ind., Sept. 29, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
-
WEST LAFAYETTE, Ind., Sept. 20, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
-
WEST LAFAYETTE, Ind., Aug. 15, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
-
WEST LAFAYETTE, Ind., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
-
– Reached Maximum Tolerated Dose in Twice Weekly Dosing Schedule with EC1456 – – Initiating EC1456 Expansion Cohort in Targeted Population of Folate Receptor-Positive Non-Small Cell Lung...
-
WEST LAFAYETTE, Ind., July 28, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc., (NASDAQ:ECYT) announced today that the company will host a conference call on Thursday, August 4th, at 4:30 p.m. EDT to...